Case Studies
Explore real-world examples of how our platform is accelerating the future of drug discovery and creating new therapeutic possibilities.
A System and Method for Targeted Modulation of Hostile Tissue Microenvironments
Our platform has outlined a system and method to precisely alter hostile tissue microenvironments, opening a new therapeutic frontier for treating chronic and autoimmune diseases.
Re-engineering Recovery: A New Path for Chronic Spinal Cord Injury
Our platform identified a novel neuro-regenerative pathway by analyzing genomic data from extremophile organisms, leading to a new therapeutic hypothesis for nerve repair.
AI-Generated Asset: A New Paradigm for Type 1 Diabetes
By modeling the complex interplay between the immune system and metabolic pathways, our AI generated a novel molecule designed to protect insulin-producing cells.
Unlocking New Potential: An Antibiotic Reimagined for Type 2 Diabetes
Counter-intuitively, our AI found that a specific antibiotic, at a targeted dose, can selectively modulate the gut microbiome and leverage its anti-inflammatory properties to improve insulin sensitivity.